• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • EPO Revokes Regenlab PRP Patent americanpharmaceuticalreview
    May 22, 2019
    Estar Technologies announced the Opposition Division of the European Patent Office (EPO) has revoked Regen Lab SA (Regenlab)'s platelet rich plasma (PRP) patent in its entirety due to lack of novelty and added matter.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service